Diabetes Prevalence Assessment Treatment Articles & Analysis: Older
12 articles found
Diabetes, specifically Type 1 and Type 2 Diabetes Mellitus, remains one of the most commonly encountered metabolic diseases worldwide. The complexity and diversity of these conditions necessitate the development of detailed medical models for a comprehensive understanding of the diseases. Over time, Type 1 and Type 2 Diabetes Mellitus Models, Metabolic Disease Models, and generalized Diabetes ...
Diabetes Prevalence Assessment In 2021, there will be approximately 529 million diabetic patients of all ages in the world, and the global age-standardized prevalence rate is about 6.1%. ...
Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity. Until now, both ...
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. The surgeon took the patient to the OR for debridement, drained the infection, and started antibiotics. The patient was treated with advanced modalities that included NPWT and a bioengineered skin substitute. Primary Diagnosis ...
What is diabetic neuropathy? The most common complication of diabetes is neuropathy, which is nerve damagecaused by high blood sugar. Most neuropathy affects the legs, hands and feet and usually presents as numbness, pain or tingling. Diabetic neuropathy can also seriously impact the heart, blood vessels, digestive system and the kidneys. Symptoms can range from mild discomfort to extreme pain. ...
Lifestyle can have a big impact on how your body handles blood glucose and sometimes a change in habits and activities is all that’s needed to prevent or better manage diabetes. But if changes in lifestyle aren’t enough to keep blood sugar levels normal, your doctor may prescribe medication to help lower insulin levels or insulin therapy. We’ll discuss here the most often ...
For a long time, electrophilic groups have been a minefield in drug development. Therefore, in the classic medicinal chemistry textbooks of the past, it is always recommended to avoid introducing functional groups such as epoxide, acridine and Michael receptor into the structure of drug molecules, because these functional groups are highly reactive and may interact with a wide range of biological ...
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it had applied to NMPA (formerly CFDA) for classification of its plasma-generated nitric oxide device for the purposes of conducting clinical trials in Hong Kong and mainland China, and that NMPA had accepted its submission. A determination is expected within sixty business days. Origin is in preliminary ...
A team of Jerusalem-based researchers and entrepreneurs claim they have a cure for diabetesthat could hit the market as early as within the next few years. Betalin Therapeutics has developed the first bio-artificial pancreas, composed of pig’s lung tissue and insulin secreting cells. The artificial pancreas would be implanted into the patient and connect with his or her blood vessels, ...
From ancient times, the applied use of herbs has been common among indigenous people throughout the world. This study consists of valuing the traditional natural heritage of the Douala region, through an ethnobotany’s study that has been conducted to collect as much information as possible about therapeutic uses of plants. This survey was done through semi-structured interviews of ...
Glucose clamping has become a standard, widely used technique in researching diabetes treatment as well as obesity and fatty liver studies. We've taken a look at the types and applications of clamp study and their impact on the field. The Glucose clamp technique was first developed in 1979 by professors at the UT School of Medicine: DeFronzo, Andres and Tobin as a method of measuring insulin ...
Diabetes is a chronic disease that currently affects approximately 8% of the US population, and that number is expected to increase significantly by the year 2030. It is imperative that effective monitoring and treatment options be available to patients. Nanotechnology is a focal point in diabetes research, where nanoparticles in particular are showing great promise in improving the treatment and ...